-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Research Institute Introduction
Target Positioning: Through innovation-driven development, continuously introducing new varieties, and building an innovative platform with independent innovation capabilities and core competitiveness!
A central research institute has been established, with R&D centers in Beijing and Jinan, forming a pattern of innovation that complements and supports each other in the north and south. A strategic cooperation with Nuokangda Pharmaceutical has led to the establishment of the Beijing R&D center, focusing on innovative and improved innovative products, as well as the R&D of high-end raw/auxiliary materials, medical beauty materials, and intermediates, providing key technological support for the upgrading of the pharmaceutical industry. The Jinan R&D center houses raw material medicine center, preparation center, musk ketone center, biomanufacturing center, and a pilot CDMO platform, comprehensively undertaking technological improvements and product landing production. It complements the Beijing R&D center, jointly promoting the efficient transformation of the company's R&D achievements. The R&D team is led by former CDE reviewers and doctors, with more than 40% of personnel holding master's degrees or above.

|
Internal and External Synergy, Complementary Advantages A chemical medicine research institute has been established to coordinate and manage R&D resources. Through strategic cooperation with Nuokangda, a Beijing research institute has been established. Through internal and external synergy, complementary advantages are achieved, accelerating product R&D and market launch, and gaining a competitive edge for the company. |
Performance Reform, Stimulating Efficiency Performance reform has been implemented, with the R&D team receiving 5-10% of the net profit after commercialization, enhancing team responsibility and engagement. Through technology-based evaluations, the focus is guided towards core technological breakthroughs, improving the institute's competitiveness and influence within the industry. |
Innovation-Driven, Process Upgrade Improving yield, reducing impurities, introducing green intelligent manufacturing, reducing production costs, and improving product quality. Through process upgrades such as continuous flow manufacturing and synthetic biology new technologies, production efficiency and product quality are improved, enhancing the company's core competitiveness. |
Team Leaders
Tao Xiu Mei
Wu Zhongyu
Zhang Jsong
Zhang Junliang
Fang Hao
Ma Shutao
Chen Xusheng
Chang Zhongwen
Wang Minggang
Crown
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline